Methotrexate is what class of anti cancer drug –
The core concept here is the classification of anti-cancer drugs. Antimetabolites are a class that interfere with DNA synthesis by mimicking natural metabolites. Methotrexate specifically inhibits dihydrofolate reductase, which is needed for folate metabolism. That leads to a lack of nucleotides for DNA and RNA synthesis.
Now, the correct answer is D. Antimetabolite. I need to explain why that's right. The mechanism involves inhibiting DHFR, causing a folate deficiency. This stops rapidly dividing cells, which is why it's used in cancers and autoimmune conditions.
The other options would be incorrect. For example, if option A was an alkylating agent, those work by cross-linking DNA. Option B might be a topoisomerase inhibitor, which affects DNA replication. Option C could be a plant alkaloid, like vincristine, which disrupts microtubules. Each of these mechanisms is different from Methotrexate's.
Clinical pearl: Remember that Methotrexate is a folate antagonist, and high-dose therapy requires leucovorin rescue to prevent toxicity. Also, it's used in both oncology and rheumatology. Students should note that even low doses in autoimmune diseases can have significant effects due to the same mechanism.
Make sure the explanation is concise, under 2500 characters. Check the formatting for bold sections and correct labels. Avoid markdown except for the specified sections. Use precise terms like "dihydrofolate reductase" and "folate metabolism." Ensure each incorrect option is clearly explained why it's wrong. End with the correct answer line.
**Core Concept**
Methotrexate is classified as an **antimetabolite**, a class of antineoplastic drugs that inhibit nucleotide synthesis by interfering with folate metabolism. Its mechanism involves competitively inhibiting dihydrofolate reductase (DHFR), a key enzyme required for tetrahydrofolate production, which is essential for purine and pyrimidine synthesis.
**Why the Correct Answer is Right**
Methotrexate acts as a **folate antagonist** by reversibly binding to DHFR, blocking the reduction of dihydrofolate to tetrahydrofolate. This depletes intracellular folate pools, impairing DNA, RNA, and protein synthesis in rapidly dividing cells (e.g., cancer cells). It is particularly effective in leukemias, lymphomas, and solid tumors like breast cancer.
**Why Each Wrong Option is Incorrect**
**Option A:** Alkylating agents (e.g., cyclophosphamide) directly add alkyl groups to DNA, causing cross-linking. Methotrexate does not alkylate DNA.
**Option B:** Topoisomerase inhibitors (e.g., etoposide) disrupt DNA replication by stabilizing enzyme-DNA complexes. Methotrexate has no effect on topoisomerases.
**Option C:** Plant alkaloids (